Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer (Q43061055)
scientific article published on 17 May 2010
Language:
(P31) (Q13442814)
(P50) (Q33120580)
(Q90926732)
(P304) 3076-3083
(P407) (Q1860)
(P433) 18
(P478) 28
(P577) Monday, May 17, 2010
(P921) (Q42824440)
(Q6995920)
(P1433) (Q400292)
(P1476) "Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer" (language: en)
(P2093) Benjamin Besse
Thomas J Lynch
Vincent A Miller
Kwok K Wong
Barbara Gitlitz
Keith Eaton
Charles Zacharchuk
Amy Freyman
Christine Powell
Revathi Ananthakrishnan
Susan Quinn
other details
description scientific article published on 17 May 2010

External Links